Diligent Investors LLC Buys 6,166 Shares of DuPont de Nemours, Inc. $DD

Diligent Investors LLC grew its stake in DuPont de Nemours, Inc. (NYSE:DD) by 291.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,285 shares of the basic materials company’s stock after buying an additional 6,166 shares during the period. Diligent Investors LLC’s holdings in DuPont de Nemours were worth $1,076,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Cardinal Capital Management increased its position in shares of DuPont de Nemours by 39.9% in the 3rd quarter. Cardinal Capital Management now owns 7,260 shares of the basic materials company’s stock valued at $943,000 after acquiring an additional 2,069 shares during the period. TI Trust Inc. raised its stake in DuPont de Nemours by 429.8% in the 3rd quarter. TI Trust Inc. now owns 14,841 shares of the basic materials company’s stock worth $1,928,000 after acquiring an additional 12,040 shares during the last quarter. Crossmark Global Holdings Inc. purchased a new position in DuPont de Nemours in the 3rd quarter worth $18,221,000. Quadrant Capital Group LLC lifted its position in DuPont de Nemours by 230.6% during the 3rd quarter. Quadrant Capital Group LLC now owns 12,791 shares of the basic materials company’s stock worth $1,661,000 after acquiring an additional 8,922 shares during the period. Finally, Physician Wealth Advisors Inc. lifted its position in DuPont de Nemours by 223.1% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 210 shares of the basic materials company’s stock worth $27,000 after acquiring an additional 145 shares during the period. 73.96% of the stock is currently owned by institutional investors and hedge funds.

DuPont de Nemours Stock Up 0.9%

DD stock opened at $134.11 on Thursday. The company has a market capitalization of $18.11 billion, a P/E ratio of 298.08, a price-to-earnings-growth ratio of 1.23 and a beta of 1.05. DuPont de Nemours, Inc. has a 12 month low of $99.20 and a 12 month high of $157.98. The firm’s fifty day simple moving average is $132.62 and its 200-day simple moving average is $138.13. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.43 and a quick ratio of 1.82.

DuPont de Nemours (NYSE:DD) last issued its earnings results on Tuesday, August 4th. The basic materials company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.76 by $0.12. The firm had revenue of $1.82 billion during the quarter, compared to analysts’ expectations of $1.81 billion. DuPont de Nemours had a net margin of 0.67% and a return on equity of 6.92%. The firm’s revenue was up 4.0% compared to the same quarter last year. During the same quarter last year, the company posted $1.12 earnings per share. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. As a group, equities research analysts forecast that DuPont de Nemours, Inc. will post 7.25 earnings per share for the current year.

DuPont de Nemours Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, November 30th will be paid a dividend of $0.60 per share. The ex-dividend date is Monday, November 30th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 1.8%. DuPont de Nemours’s dividend payout ratio (DPR) is presently 533.33%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on DD. Zacks Research downgraded DuPont de Nemours from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 17th. JPMorgan Chase & Co. lowered DuPont de Nemours from an “overweight” rating to a “neutral” rating and cut their price objective for the company from $172.00 to $145.00 in a report on Friday, October 9th. The Goldman Sachs Group reduced their price objective on DuPont de Nemours from $159.00 to $153.00 and set a “neutral” rating for the company in a research note on Wednesday, September 30th. Citigroup reduced their price objective on DuPont de Nemours from $170.00 to $162.00 and set a “buy” rating for the company in a research note on Wednesday, October 7th. Finally, Barclays began coverage on DuPont de Nemours in a report on Tuesday, October 13th. They set an “overweight” rating and a $156.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $162.00.

DuPont de Nemours Company Profile

DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.

The company’s product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.